PMC:7362084
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T1 | 0-8 | Body_part | denotes | Antibody | http://purl.org/sig/ont/fma/fma62871 |
T2 | 340-348 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
2 | 27-37 | Species | denotes | SARS‐CoV‐2 | Tax:2697049 |
3 | 41-49 | Disease | denotes | COVID‐19 | MESH:C000657245 |
12 | 148-195 | Species | denotes | severe acute respiratory syndrome coronavirus 2 | Tax:2697049 |
13 | 197-207 | Species | denotes | SARS‐CoV‐2 | Tax:2697049 |
14 | 367-377 | Species | denotes | SARS‐CoV‐2 | Tax:2697049 |
15 | 468-478 | Species | denotes | SARS‐CoV‐2 | Tax:2697049 |
16 | 546-554 | Species | denotes | patients | Tax:9606 |
17 | 102-126 | Disease | denotes | coronavirus disease 2019 | MESH:C000657245 |
18 | 128-136 | Disease | denotes | COVID‐19 | MESH:C000657245 |
19 | 537-545 | Disease | denotes | COVID‐19 | MESH:C000657245 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 27-31 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T2 | 41-49 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T3 | 102-126 | Disease | denotes | coronavirus disease 2019 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T4 | 128-136 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T5 | 148-195 | Disease | denotes | severe acute respiratory syndrome coronavirus 2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T6 | 148-181 | Disease | denotes | severe acute respiratory syndrome | http://purl.obolibrary.org/obo/MONDO_0005091 |
T7 | 197-201 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T8 | 367-371 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T9 | 468-472 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T10 | 537-545 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 209-212 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T2 | 220-221 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-58 | Sentence | denotes | Antibody responses against SARS‐CoV‐2 in COVID‐19 patients |
T2 | 59-69 | Sentence | denotes | LIU et al. |
T3 | 71-79 | Sentence | denotes | Abstract |
T4 | 80-88 | Sentence | denotes | Abstract |
T5 | 89-324 | Sentence | denotes | The emerging coronavirus disease 2019 (COVID‐19) caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has become a global pandemic, and brings formidable challenges to public health, society and the economy worldwide. |
T6 | 325-402 | Sentence | denotes | Currently, the antibody responses against SARS‐CoV‐2 remains largely unknown. |
T7 | 403-570 | Sentence | denotes | We herein estimated the longevity of specific antibodies against SARS‐CoV‐2, and reported that antibodies waned over substantially in COVID‐19 patients after recovery. |
T8 | 571-610 | Sentence | denotes | This article is protected by copyright. |
T9 | 611-631 | Sentence | denotes | All rights reserved. |